Placental Stem Cell Collection and Storage Market to witness an impressive grow – News by aeresearch

The research report, titled [Global Placental Stem Cell Collection and Storage market 2020 by Manufacturers, Type and Application, Forecast to 2025], presents a detailed analysis of the drivers and restraints impacting the overall market. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of the achievements made by the players in the global Placental Stem Cell Collection and Storage market so far. It also notes the key trends in the market that are likely to be lucrative. The research report aims to provide an unbiased and a comprehensive outlook of the global Placental Stem Cell Collection and Storage market to the readers.

The Placental Stem Cell Collection and Storage market report offers a comprehensive analysis of this industry vertical, emphasizing on the key growth stimulants, opportunities, and constraints projected to shape the market dynamics over the forecast period.

As per industry experts, the market is anticipated to grow significantly, registering a CAGR of XX% over the analysis period of 2020-2025

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/293040

Instabilities in the supply & demand channels due to the stringent lockdown measures imposed to address the COVID-19 pandemic has left numerous companies in disarray. Speaking of the ambiguity of revenues in the near term, businesses are expected to face hindrance even once the economy recovers from the pandemic.

Additionally, the report offers a holistic assessment of various industry segments to infer the revenue projections for the market over the study duration.

Key inclusions of the Placental Stem Cell Collection and Storage market report:

Placental Stem Cell Collection and Storage Market segments covered in the report:

Regional analysis: North America, Europe, Asia-Pacific, South America and Middle East and Africa

Product spectrum: Placental Subtopotent Stem Cells, Placental Hematopoietic Stem Cells, Placental Mesenchymal Stem Cells (MSC) and Placental Maternal Pluripotent Stem Cells

Applications spectrum: Cell Therapy, Beauty Products and Other

Competitive landscape:

Information including major players operating in the market along with the manufacturing facilities as well as competitors of each participant

Questions Answered by the Report:

What will be the size of the global Placental Stem Cell Collection and Storage market in 2025?

What is the current CAGR of the global Placental Stem Cell Collection and Storage market?

Which product is expected to show the highest market growth?

Which application is projected to gain a lions share of the global Placental Stem Cell Collection and Storage market?

Which region is foretold to create the most number of opportunities in the global Placental Stem Cell Collection and Storage market?

Will there be any changes in market competition during the forecast period?

Which are the top players currently operating in the global Placental Stem Cell Collection and Storage market?

How will the market situation change in the coming years?

What are the common business tactics adopted by players?

What is the growth outlook of the global Placental Stem Cell Collection and Storage market?

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/293040

Read more from the original source:
Placental Stem Cell Collection and Storage Market to witness an impressive grow - News by aeresearch

Stem Cell Market 2020: Share Value Analysis of Top Key Players, Global Size, Consumption Analysis, Trends Forecast to 2024 | Industry Research.co -…

Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Stem Cell market report presents in-depth analysis regarding the development, current trends, industry policies, and regulations implemented in each of the geographical regions. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Stem Cell market report provides an in-depth insight into Stem Cell industry during 2020-2024.

Scope of the Report:

The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.

Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.industryresearch.co/enquiry/pre-order-enquiry/13999718

Key Market Trends:

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.

Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.

Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

Reasons to Buy Stem Cell Market Report:

Purchase this Report (Price 4250 USD for a Single-User License) https://www.industryresearch.co/purchase/13999718

Stem Cell Market Report Covers the Following Questions:

Detailed TOC of Stem Cell Market 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Increased Awareness about Umbilical Stem Cell 4.2.2 Increase in the Approval for Clinical Trials in Stem Cell Research 4.2.3 Growing Demand for Regenerative Treatment Option 4.2.4 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases 4.3 Market Restraints 4.3.1 Expensive Procedures 4.3.2 Regulatory Complications 4.3.3 Ethical and Moral Framework 4.4 Industry Attractiveness- Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Product Type 5.1.1 Adult Stem Cell 5.1.2 Human Embryonic Cell 5.1.3 Pluripotent Stem Cell 5.1.4 Other Product Types 5.2 By Therapeutic Application 5.2.1 Neurological Disorders 5.2.2 Orthopedic Treatments 5.2.3 Oncology Disorders 5.2.4 Diabetes 5.2.5 Injuries and Wounds 5.2.6 Cardiovascular Disorders 5.2.7 Other Therapeutic Applications 5.3 By Treatment Type 5.3.1 Allogeneic Stem Cell Therapy 5.3.2 Auto logic Stem Cell Therapy 5.3.3 Syngeneic Stem Cell Therapy 5.4 By Banking Service and Technology 5.4.1 Stem Cell Acquisition and Testing 5.4.2 Cell Production 5.4.3 Expansion 5.4.4 Sub-culture 5.4.5 Cryopreservation 5.5 By Type of Banking 5.5.1 Public 5.5.2 Private 5.6 Geography 5.6.1 North America 5.6.1.1 US 5.6.1.2 Canada 5.6.1.3 Mexico 5.6.2 Europe 5.6.2.1 UK 5.6.2.2 Germany 5.6.2.3 France 5.6.2.4 Italy 5.6.2.5 Spain 5.6.2.6 Rest of Europe 5.6.3 Asia-Pacific 5.6.3.1 China 5.6.3.2 Japan 5.6.3.3 India 5.6.3.4 Australia 5.6.3.5 South Korea 5.6.3.6 Rest of Asia-Pacific 5.6.4 Middle East & Africa 5.6.4.1 GCC 5.6.4.2 South Africa 5.6.4.3 Rest of Middle East & Africa 5.6.5 South America 5.6.5.1 Brazil 5.6.5.2 Argentina 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Osiris Therapeutics Inc. 6.1.2 Pluristem Therapeutics Inc. 6.1.3 Thermo Fisher Scientific 6.1.4 Qiagen NV 6.1.5 Sigma Aldrich Corporation 6.1.6 Becton, Dickinson and Company 6.1.7 Stem Cell Technologies Inc. 6.1.8 AllCells LLC 6.1.9 Miltenyi Biotec 6.1.10 International Stem Cell Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Omega 3 Products Market Insights on Global Share 2020 Latest Industry Trends, Market Demand, Growth, Opportunities and Forecast 2026

Mattress Supports Market Size and Share Forecast Analysis, Top Key Players, Latest Developments, Growth Factors till 2020 to 2024 | Research Report by Industry Research.co

Automotive Metal Coil Spring Market Growth by Forthcoming Developments 2020 Global Industry Scope, Future Prospects, Manufacturers with Size and Share Analysis till 2026 | Report by Industry Research.co

Healthcare 3D Printing Market Share and Business Development 2020 Future Plans of Top Companies, Growth Size, Industry Share by Latest Trends Forecast to 2025

Human Microbiome Sequencing Market Business Growth Analysis with COVID-19 Impact, Future Trends, Industry Size, Global Share and Demand Status Forecast to 2026 Available at Industry Research.co

Underfloor Heating and Cooling Market Growth, Industry Trends 2020 Size by Regions, Global Industry Share, Sales Revenue and Opportunities till 2026 with COVID-19 Impact

Casing Heads Market Size, Share | Growth Analysis by Revenue, Future Demand Status, Price Analysis by Types and Applications till 2020-2026

Engine Cooling Pumps Market Share and Forecast by 2020 to 2026 | Top Key Players Analysis Covers Regions with Growth Value, Comprehensive Development Strategy, Global Size with Revenue and COVID-19 Impact

Read more:
Stem Cell Market 2020: Share Value Analysis of Top Key Players, Global Size, Consumption Analysis, Trends Forecast to 2024 | Industry Research.co -...

Industrial Centrifuge Market worth $9.0 billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

CHICAGO, Sept. 4, 2020 /PRNewswire/ -- According to the new market research report "Industrial Centrifuge Marketby Type (Sediment, Clarifier, Decanter, Disc, Filter, Basket, Screen), Operation (Batch, Continuous), Design (Horizontal, Vertical), End User (Chemical, Power, Food, Wastewater, Pharmaceutical, Paper) and Region - Global Forecast to 2025", published by MarketsandMarkets,the global Industrial Centrifuge Market is projected to reach USD 9.0 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 4.4% between 2020 and 2025.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59612221

The increasing demand for centrifuges in process industries and the rising need for wastewater management solutions are the major factors driving the growth of this market. However, the high cost of centrifuges is expected to restrain the market growth during the forecast period.

Sedimentation centrifuges to dominated the industrial centrifuge market in 2019

On the basis of type, the market is segmented into sedimentation centrifuges and filtering centrifuges. In 2019, the sedimentation centrifuge segment accounted for the largest share of the market. The wide range of industrial applications, the ability to achieve high speeds, increase in oil and gas explorations, and the rising need for wastewater treatment are the major factors contributing to the growth of this segment.

Browsein-depth TOC on"Industrial Centrifuge Market"

232 Tables 33 Figures 227 Pages

Clarifier segment accounted for the largest share of the sedimentation centrifuge market, by type, in 2019

On the basis of type, the sedimentation centrifuge market is segmented into clarifiers/thickeners, decanter centrifuges, disk stack centrifuges, hydrocyclones, and other sedimentation centrifuges. In 2019, the clarifier/thickener segment accounted for the largest share of the sedimentation centrifuges market. These centrifuges are used in a number of industries, including wastewater treatment, mining, power, beverages, food processing, pharmaceuticals and biotechnology, and chemicals.

North America is the largest regional market for industrial centrifuge in 2019

In 2019, North America accounted for the largest share of the industrial centrifuge market, followed by Europe. The high demand for crude oil, a large number of shale oil and gas drilling activities, government initiatives to manage wastewater, flourishing food processing industry, technological advancements, and government support for the development of innovative centrifugation systems are the key factors driving the growth of the market in North America.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=59612221

Prominent players in the industrial centrifuge market are ANDRITZ AG (Austria), Alfa Laval Corporate AB (Sweden), GEA Group AG (Germany), Mitsubishi Kakoki Kaisha, Ltd. (Japan), Thomas Broadbent & Sons (UK), FLSmidth & Co. A/S (Denmark), Schlumberger Limited (US), Ferrum AG (Switzerland), Flottweg SE (Germany), SIEBTECHNIK TEMA (Germany), HEINKEL Drying & Separation Group (Germany), Gruppo Pieralisi - MAIP S.p.A. (Italy), SPX Flow Inc. (US), HAUS Centrifuge Technologies (Turkey), Elgin Separation Solutions (US), Comi Polaris Systems, Inc. (US), Dedert Corporation (US), US Centrifuge Systems (US), B&P Littleford (US), and Pneumatic Scale Angelus (US).

Browse Adjacent Markets:Medical Devices Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:

https://www.marketsandmarkets.com/RequestBundleReport.asp?id=59612221

Browse Related Reports:

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html

Laboratory Centrifuge Market by Product (Equipment (Multipurpose, Ultracentrifugation), Accessories (Rotor, Tube, Bucket, Plate)), Model (Benchtop, Floor standing), Application (Microbiology, Proteomics) & End User (Hospitals) - Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/laboratory-centrifuge-market-197749088.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish MehraMarketsandMarkets INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [emailprotected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/industrial-centrifuges-market.asp Visit Our Website: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/industrial-centrifuges.asp

SOURCE MarketsandMarkets

Read more:
Industrial Centrifuge Market worth $9.0 billion by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire

New Comprehensive Report on Cell Separation Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Mitenyi Biotec, BD…

Cell Separation Industry Analysis 2020

TheCell Separation Marketreport enlightens its readers about its products, applications, and specifications. The research enlists key companies operating in the market and also highlights the roadmap adopted by the companies to consolidate their position in the market.By extensive usage of SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and combination of key companies are comprehensively deduced and referenced in the report.Every single leading player in this global market is profiled with their related details such as product types, business overview, sales, manufacturing base, applications, and other specifications.

Major Market Players Covered In This Report:, Mitenyi Biotec, BD Bioscience, STEMCELL Technologies Terumo, pluriSelect, Millipore (Merck), Life Technologies

Click Here To Access The Sample Report:https://grandviewreport.com/sample/20572

Cell SeparationMarket has exhibited continuous growth in the recent past and is projected to grow even more throughout the forecast. The analysis presents an exhaustive assessment of the market and comprises Future trends, Current Growth Factors, attentive opinions, facts, historical information, in addition to statistically supported and trade validated market information.

The Global Cell SeparationMarket Can Be Segmented As

The key product type of Cell Separationmarket are:, Gradient centrifugation, Surface markers separation, Fluorescence activated cell sorting, Magnetic cell sorting

Cell SeparationMarket Outlook by Applications:, Oncology research, Neuroscience research, Stem cell research

To Get This Report At Beneficial Rates:https://grandviewreport.com/discount/20572

The Cell Separationmarket comprising of well-established international vendors is giving heavy competition to new players in the market as they struggle with technological development, reliability and quality problems the analysis report examines the expansion, market size, key segments, trade share, application, and key drivers.

Key players within the Cell Separationmarket are identified through secondary analysis, and their market shares are determined through primary and secondary analysis. The report encloses a basic summary of the trade lifecycle, definitions, classifications, applications, and trade chain structure. Each of these factors can facilitate leading players to perceive the scope of the Market, what unique characteristics it offers and the manner in which it will fulfill a customers need.

By Company Profile, Product Image and Specification, Product Application Analysis, Production Capability, Price Cost, Production Value, Contact Data are included in this research report.

What Cell SeparationMarket report offers: Cell SeparationMarket share assessments for the regional and country-level segments Market share analysis of the highest trade players Cell SeparationMarket Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations) Strategic recommendations on key business segments

The Report Answers Following Questions: Over successive few years, which Cell Separationapplication segment can perform well? Within which market, the businesses ought to establish a presence? Which product segments are exhibiting growth? What are the market restraints which are likely to impede the growth rate? However, market share changes their values by completely different producing brands?

To Know More About The Assumptions in This Market Report:http://grandviewreport.com/industry-growth/Cell-Separation-Market-20572

The report entails detailed profiling of each company, and information on capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments, are also included within the scope of the report. In the end, the Cell SeparationMarket Report delivers a conclusion which includes Breakdown and Data Triangulation, Consumer Needs/Customer Preference Change, Research Findings, Market Size Estimation, Data Source. These factors are expected to augment the overall business growth.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.

Original post:
New Comprehensive Report on Cell Separation Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Mitenyi Biotec, BD...

Long weekend reads: What are the risks of rushing a vaccine? 1976 offers some troubling warnings. – The Daily Briefing

September 4, 2020 Ben Palmer's reads

Devo co-founder Mark Mothersbaugh had Covid-19and some 'very dark' delusions. Mark Mothersbaugh, co-founder of the band Devo, was hospitalized with Covid-19 in May, and in a recent interview with the Los Angeles Times, Mothersbaugh opened up about his experiencing fighting the disease while on a ventilator in the ICU. Mothersbaugh talks about the "very dark" delusions he experienced while in the hospital, including believing he was in the ICU because someone had hit him in the head with a brick. "I felt blood from being hit," he said. "I was handcuffed to a parking deck downtown. I had this whole elaborate story of how these kids sold me to an ambulance company that then got some sort of payment for delivering Covid patients to their ICUs. I totally believed it."

The century-long history of convalescent plasma. Convalescent plasma has garnered a lot of attention in recent weeksand last month, FDA in a controversial move issued an emergency use authorization for the therapy as potential treatment for Covid-19. Writing for the Smithsonian Magazine, Jillian Mock examines the history of convalescent plasma, which dates back to the late 19th and early 20th century, when it was used to treat measles, Spanish influenza, and a variety of other diseases.

What can happen when you fast-track a vaccine approval? History lends a forbidding answer. Writing in the New York Times, Rick Perlstein explains what happened during the 1976 election year, when former President Gerald Ford accelerated the development and approval of a vaccine against a new strain of the H1N1 viruswhich appeared to be related to the pathogen that caused the 1918 flu pandemic. The vaccine, which the federal government distributed through a mass vaccination campaign, had unexpected side effects. An estimated 450 of the 45 million Americans who were inoculated with the new vaccine developed a rare disorder called Guillain-Barr syndrome, which paralyzes the body, including 30 who died. In the end, the federal government ended its mass vaccination campaignand Ford lost the election.

Scientists discover a key to a longer and healthier lifefor mice. A study published Tuesday in Cell Metabolism showed mice that were given a naturally occurring metabolite were healthier overall, and sicker for shorter periods before dying, when compared with mice in a control group. For the study, scientists at the Buck Institute for Research on Aging evaluated the effects of a metabolite called alpha-ketoglutarate (AKG)which is naturally found in the body and a plays a role in several biological process, including stem cell growthon 18-month-old mice, meaning they were approximately between ages 55 to 66 in human years. The scientists said they hope their research will pave the way for studies on therapies that could improve quality of life among elderly humans.

Continue reading here:
Long weekend reads: What are the risks of rushing a vaccine? 1976 offers some troubling warnings. - The Daily Briefing

Cell Therapy Market Brief Analysis and Application, Growth by 2026 – Scientect

LOS ANGELES, United States: QY Research has recently published a report, titled Global Cell Therapy Market Professional Survey Report 2020. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Cell Therapy market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.

Key Companies/Manufacturers operating in the global Cell Therapy market include: Gilead Sciences Novartis Osiris Vericel Corporation Vcanbio Fujifilm Cellular Dynamics JCR Pharmaceuticals Beike Biotechnology Golden Meditech Guanhao Biotech Segment by Type, , , Stem Cell Non-Stem Cell Segment by Application Hospital Clinic Other By Region North America Europe Japan China Southeast Asia India

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1916335/global-cell-therapy-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Cell Therapy market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Cell Therapy Market Segment By Type:

Stem Cell Non-Stem Cell

Global Cell Therapy Market Segment By Application:

Market Analysis and Insights: Global Cell Therapy Market The global Cell Therapy market was valued at US$ 77485 million in 2019 and it is expected to reach US$ 362235 million by the end of 2026, growing at a CAGR of 27.18% during 2020-2026. Global Cell Therapy Scope and Market Size Cell Therapy market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cell Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyzes the impact of Coronavirus COVID-19 on the Cell Therapy industry. By Company Gilead Sciences Novartis Osiris Vericel Corporation Vcanbio Fujifilm Cellular Dynamics JCR Pharmaceuticals Beike Biotechnology Golden Meditech Guanhao Biotech Segment by Type

Stem Cell Non-Stem Cell Segment by Application Hospital Clinic Other By Region North America Europe Japan China Southeast Asia India

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Cell Therapy market.

Key companies operating in the global Cell Therapy market include Gilead Sciences Novartis Osiris Vericel Corporation Vcanbio Fujifilm Cellular Dynamics JCR Pharmaceuticals Beike Biotechnology Golden Meditech Guanhao Biotech Segment by Type, , , Stem Cell Non-Stem Cell Segment by Application Hospital Clinic Other By Region North America Europe Japan China Southeast Asia India

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1916335/global-cell-therapy-market

TOC

1 REPORT OVERVIEW1 1.1 Study Scope1 1.2 Key Market Segments1 1.3 Players Covered: Ranking by Cell Therapy Revenue2 1.4 Market Analysis by Type2 1.4.1 Global Cell Therapy Market Size Growth Rate by Type: 2020 VS 20262 1.4.2 Stem Cell4 1.4.3 Non-Stem Cell5 1.5 Market by Application6 1.5.1 Global Cell Therapy Market Share by Application: 2020 VS 20266 1.5.2 Hospital8 1.5.3 Clinic8 1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth9 1.6.1 How the Covid-19 is Affecting the Cell Therapy Industry9 1.6.2 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections11 1.6.3 Covid-19 Impact: Commodity Prices Indices20 1.6.4 Covid-19 Impact: Global Major Government Policy25 1.6.5 Proposal for Cell Therapy Players to Combat Covid-19 Impact29 1.7 Study Objectives31 1.8 Years Considered31 2 GLOBAL GROWTH TRENDS32 2.1 Global Cell Therapy Market Perspective (2015-2026)32 2.2 Cell Therapy Growth Trends by Regions33 2.2.1 Cell Therapy Market Size by Regions: 2015 VS 2020 VS 202633 2.2.2 Cell Therapy Historic Market Size by Regions (2015-2020)35 2.2.3 Cell Therapy Forecasted Market Size by Regions (2021-2026)35 2.3 Industry Trends and Growth Strategy37 2.3.1 Market Top Trends37 2.3.2 Market Drivers37 2.3.3 Market Challenges38 2.3.4 Porter Five Forces Analysis39 2.3.5 Advantages of Allogeneic Over Autologous Cell Therapy Products40 3 COMPETITION LANDSCAPE BY KEY PLAYERS42 3.1 Global Top Cell Therapy Players by Market Size42 3.1.1 Global Top Cell Therapy Players by Revenue (2019-2020)42 3.1.2 Global Cell Therapy Revenue Market Share by Players (2019-2020)43 3.1.3 Global Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)44 3.2 Global Cell Therapy Market Concentration Ratio44 3.2.1 Global Cell Therapy Market Concentration Ratio (CR5)44 3.2.2 Global Top 5 Companies by Cell Therapy Revenue in 201945 3.3 Cell Therapy Key Players Head office and Area Served45 3.4 Key Players Cell Therapy Product Solution and Service46 3.5 Date of Enter into Cell Therapy Market46 3.6 Mergers & Acquisitions, Expansion Plans47 4 CELL THERAPY BREAKDOWN DATA BY TYPE (2015-2026)51 4.1 Global Cell Therapy Historic Market Size by Type (2015-2020)51 4.2 Global Cell Therapy Forecasted Market Size by Type (2021-2026)52 5 CELL THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)54 5.1 Global Cell Therapy Historic Market Size by Application (2015-2020)54 5.2 Global Cell Therapy Forecasted Market Size by Application (2021-2026)55 6 NORTH AMERICA57 6.1 North America Cell Therapy Market Size (2015-2026)57 6.2 Cell Therapy Key Players in North America (2019-2020)57 6.3 North America Cell Therapy Market Size by Type (2015-2020)58 6.4 North America Cell Therapy Market Size by Application (2015-2020)59 7 EUROPE60 7.1 Europe Cell Therapy Market Size (2015-2026)60 7.2 Cell Therapy Key Players in Europe (2019-2020)60 7.3 Europe Cell Therapy Market Size by Type (2015-2020)61 7.4 Europe Cell Therapy Market Size by Application (2015-2020)61 8 JAPAN63 8.1 Japan Cell Therapy Market Size (2015-2026)63 8.2 Cell Therapy Key Players in Japan (2019-2020)63 8.3 Japan Cell Therapy Market Size by Type (2015-2020)64 8.4 Japan Cell Therapy Market Size by Application (2015-2020)64 9 CHINA66 9.1 China Cell Therapy Market Size (2015-2026)66 9.2 Cell Therapy Key Players in China (2019-2020)66 9.3 China Cell Therapy Market Size by Type (2015-2020)67 9.4 China Cell Therapy Market Size by Application (2015-2020)67 10 SOUTHEAST ASIA69 10.1 Southeast Asia Cell Therapy Market Size (2015-2026)69 10.2 Cell Therapy Key Players in Southeast Asia (2019-2020)69 10.3 Southeast Asia Cell Therapy Market Size by Type (2015-2020)70 10.4 Southeast Asia Cell Therapy Market Size by Application (2015-2020)70 11 INDIA72 11.1 India Cell Therapy Market Size (2015-2026)72 11.2 Cell Therapy Key Players in India (2019-2020)72 11.3 India Cell Therapy Market Size by Type (2015-2020)73 11.4 India Cell Therapy Market Size by Application (2015-2020)73 12 KEY PLAYERS PROFILES75 12.1 Gilead Sciences75 12.1.1 Gilead Sciences Company Details75 12.1.2 Gilead Sciences Cell Therapy Introduction76 12.1.3 Gilead Sciences Revenue in Cell Therapy Business (2019-2020)76 12.2 Novartis77 12.2.1 Novartis Company Details77 12.2.2 Novartis Cell Therapy Introduction78 12.2.3 Novartis Revenue in Cell Therapy Business (2019-2020)79 12.3 Osiris79 12.3.1 Osiris Company Details79 12.3.2 Osiris Cell Therapy Introduction80 12.3.3 Osiris Revenue in Cell Therapy Business (2019-2020)81 12.4 Vericel Corporation81 12.4.1 Vericel Corporation Company Details81 12.4.2 Vericel Corporation Cell Therapy Introduction82 12.4.3 Vericel Corporation Revenue in Cell Therapy Business (2019-2020)83 12.5 Vcanbio83 12.5.1 Vcanbio Company Details83 12.5.2 Vcanbio Cell Therapy Introduction84 12.5.3 Vcanbio Revenue in Cell Therapy Business (2019-2020)84 12.6 Fujifilm Cellular Dynamics85 12.6.1 Fujifilm Cellular Dynamics Company Details85 12.6.2 Fujifilm Cellular Dynamics Cell Therapy Introduction86 12.6.3 Fujifilm Cellular Dynamics Revenue in Cell Therapy Business (2019-2020)86 12.7 JCR Pharmaceuticals87 12.7.1 JCR Pharmaceuticals Company Details87 12.7.2 JCR Pharmaceuticals Cell Therapy Introduction88 12.7.3 JCR Pharmaceuticals Revenue in Cell Therapy Business (2019-2020)89 12.8 Beike Biotechnology89 12.8.1 Beike Biotechnology Company Details89 12.8.2 Beike Biotechnology Cell Therapy Introduction90 12.8.3 Beike Biotechnology Revenue in Cell Therapy Business (2019-2020)90 12.9 Golden Meditech91 12.9.1 Golden Meditech Company Details91 12.9.2 Golden Meditech Cell Therapy Introduction91 12.9.3 Golden Meditech Revenue in Cell Therapy Business (2019-2020)92 12.10 Guanhao Biotech92 12.10.1 Guanhao Biotech Company Details92 12.10.2 Guanhao Biotech Cell Therapy Introduction93 12.10.3 Guanhao Biotech Revenue in Cell Therapy Business (2019-2020)94 13 ANALYSTS VIEWPOINTS/CONCLUSIONS95 14 APPENDIX96 14.1 Research Methodology96 14.1.1 Methodology/Research Approach96 14.1.2 Data Source99 14.2 Disclaimer102 14.3 Author Details102

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Visit link:
Cell Therapy Market Brief Analysis and Application, Growth by 2026 - Scientect

Can Culturing CAR T Cells With Ibrutinib Improve Their Efficacy in CLL? – Cancer Therapy Advisor

Efficacy ofchimeric antigen receptor (CAR) T-cell (CAR-T) therapies in chronic lymphocytic leukemia (CLL) have lagged behind the efficacy they appear to have in other hematological malignancies such as acute lymphoblastic leukemia or diffuse large B-cell lymphoma.

Theres a growing recognition that some of the CAR-T shortfalls in CLL are due to an impaired fitness of T cells in CLL patients. Some research has shown, however, that sustained remission of CLL is associated with enrichment of a less-differentiated, early-memory phenotype of T cells in the apheresis product used to make CAR-T therapies.1 Such findings have galvanized interest in approaches to enhance this T-cell population during the immunotherapy manufacturing process as a possible route for overcoming treatment resistance.

Now, a small study in the International Journal of Cancer reported that culturing CLL patients T cells with the tyrosine kinase inhibitor ibrutinib which among other effects, inhibits a pathway involved in T-cell differentiation boosted the viability, function, and expansion of CLL patient-derived CAR T cells as well as enriching them with a less-differentiated phenotype.2

In culture, they could prevent the T cells from differentiating when they treat with ibrutinib, and thats [creating] the seed population that you want for adoptive T-cell therapy, noted Joseph A. Fraietta, PhD, assistant professor of microbiology and director of the solid tumor immunotherapy laboratory at the center for advanced cellular therapeutics at the University of Pennsylvania, who wasnt involved in the research. If the results hold up, this could be a giant step forward, I think, for these patients who need CAR T-cell therapy to get into long-term durable remission.

For the study, a team of researchers from Germany extracted peripheral blood mononuclear cells from 8 CLL patients and 9 healthy people. They cultured them into CD19-directed CAR-T cells using standard protocols, but under 2 different conditions: 1 without ibrutinib, and 1 in the presence of ibrutinib.

In a series of analyses, the authors found that although cell proliferation during CAR-T generation was generally much lower in CLL-derived cells compared with healthy ones, the absolute numbers of CLL patient-derived CAR-T cells were substantially higher when they were cultured with ibrutinib supplementation. The ibrutinib-supplemented CAR T cells also produced more cytokines in an assay in which the cells were stimulated with a B lymphoblast cell line, and also expressed fewer cell exhaustion markers such as LAG-3, TIM-3, and PD-1, which can impede T-cell function.

Cultivating the CLL patient-derived and healthy cells with ibrutinib had no impact on the proportions of CD4+ and CD8+ T cells, but it did on the proportion of early T cells that were in a less-differentiated state. Stem cell memory-like T cells and what the authors called naive-like T cells are thought to be important for the generation of CAR T cells and their long-term persistence in vivo. Ibrutinib supplementation enriched both products derived from CLL patients and from healthy people with these phenotypes, the authors reported.

See original here:
Can Culturing CAR T Cells With Ibrutinib Improve Their Efficacy in CLL? - Cancer Therapy Advisor

Stem Cell Source Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2024 (Based on 2020 COVID-19 Worldwide…

2020 September, Magarpatta SEZ, Pune, ReportsnReports, one of the worlds prominent market research firms has released a new report on Global Stem Cell Source Market. The report contains crucial insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Stem Cell Source Market to figure out and study market needs, market size, and competition. The report talks about the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by Top key players.

Get Free Sample PDF Copy of Stem Cell Source Market with Figures, Graphs and Tocs:https://www.reportsnreports.com/contacts/requestsample.aspx?name=3515209

The report also includes the impact of ongoing global crisis i.e.COVID-19on the Stem Cell Source Market and what the future holds for it. The published report is designed using a vigorous and thorough research methodology andReportsnReportsis also known for its data accuracy and granular market reports.

Summary

The global Stem Cell Source market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumption Market by Type and End-Use Chapter 5: Asia Production & Consumption Market by Type and End-Use Chapter 6: Oceania Production & Consumption Market by Type and End-Use Chapter 7: Africa Production & Consumption Market by Type and End-Use Chapter 8: Global Market Forecast by Type, End-Use and Region Chapter 9: Company information, Sales, Cost, Margin, news etc. Chapter 10: Market Competition by Companies and Market Concentration Ratio Chapter 11: Market Impact by Coronavirus. Chapter 12: Industry Summary

Market Segment as follows:

Key Companies BD Bioscience Beckman Coulter Ge Healthcare Merck Millipore Miltenyi Biotec Pluriselect Life Science Sigma-Aldrich Corporation Stemcell Technologies Terumo BCT Thermo Fisher ScientificCompany 13

Key Types Reagent Instrument Others

Key End-Use Hospital Biotechnology Research Center Others

This report can be dispatched within 24-48 Hours.

Enquire for More Information on Stem Cell Source Market:https://www.reportsnreports.com/contacts/discount.aspx?name=3515209

The global Stem Cell Source Market is expected to witness a promising growth in the next few years. The rising level of competition among the leading players and the rising focus on the development of new products are likely to offer promising growth opportunities throughout the forecast period. The research study on the global Stem Cell Source Market offers a detailed overview, highlighting the key aspects that are expected to enhance the growth of the market in the near future. The key segmentation and the competitive landscape of the market have also been mentioned at length in the research study.

This report studies the Stem Cell Source Market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Stem Cell Source Market by product type and applications/end industries. These details further contain a basic summary of the company, merchant profile, and the product range of the company in question. The report analyzes data regarding the proceeds accrued, product sales, gross margins, price patterns, and news updates relating to the company.

Full Report available @https://www.reportsnreports.com/purchase.aspx?name=3515209

The report helps to identify the main Stem Cell Source Market players. It assists in analyzing Stem Cell Source Market competitive environment, including company overview, company total revenue, market opportunities, value, production sites and facilities, SWOT analysis, product details. The study also reveals the sales, revenue and market share for each market player included in this report for the period of 2015-2020. It also helps to ascertain the growth drivers and future prospects for the forecast timeline.

Conclusively, this report is a one stop reference point for the industrial stakeholders to get Stem Cell Source Market forecast of till 2025. This report helps to know the estimated market size, market status, future development, growth opportunity, challenges, growth drivers of by analyzing the historical overall data of the considered market segments.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

We provide 24/7 online and offline support to our customers.

E-mail: [emailprotected]

Phone: +1 888 391 5441

See original here:
Stem Cell Source Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2024 (Based on 2020 COVID-19 Worldwide...

Be The Match Presents "Sickle Cell Connect" Virtual Event Series To Raise Awareness Of Treatment Options And Marrow Transplants As A Cure…

MINNEAPOLIS, Sept. 4, 2020 /PRNewswire/ -- Sickle Cell warrior Tahir "StayFresh" Ali of Atlanta, Ga., visits the hospital twice monthly for blood transfusions to reduce complications from sickle cell disease, and manage his potential risk of organ damage or stroke. The 35-year-old music producer and manager estimates he has spent several years of his life in the hospital undergoing treatment for sickle cell disease. Finding a perfectly matched marrow or blood stem cell donor could give StayFresh a chance to live life free of sickle cell and the many complications that the disease presents.

September is Sickle Cell Awareness Month, and Be The Match, the National Marrow Donor Program, is launching several campaigns to help people to learn more about the disease, and take action to help those searching for a matching blood stem cell or marrow donor.

StayFresh is like 100,000 African Americans who battle sickle cell disease, an often-misunderstood genetic disease that is "invisible" because unlike many illnesses, people with sickle cell disease can lead active lives. However, people with severe sickle cell can face debilitating episodes of pain crisis and life-threatening complications. StayFresh is working with Be The Match to rally more Black and African Americans to join the Be The Match Registry.

Be The Match is also hosting a three-part virtual event series to raise awareness about sickle cell disease, provide free resources for patients and families affected by sickle cell, discuss treatment options, and the need for more Black donors on the Be The Match Registry. The event series and more information can be found at: SickleCellConnect.com.

"We are grateful to have a dedicated Patient Services team that is able to produce these informative virtual events to help sickle cell patients and their caregivers learn how to access free resources and advocate for themselves as they navigate their disease," said Erica Jensen, Senior Vice President of Be The Match Member Engagement, Enrollment and Experience. "Nobody with sickle cell disease has to walk alone. Be The Match has a peer connect program, free professional counseling, nurse navigators and strong partnerships with organizations like The Sickle Cell Community Consortium and My Three Sicklers Foundation to ensure we can connect caregivers and sickle cell warriors with the resources they need to best manage this disease."

According to the Centers for Disease Control, sickle cell disease is the most common inherited disease, affecting 1 in 365 Black or African Americans and 1 in 16,300 Hispanic Americans. With sickle cell disease, oxygen-carrying red blood cells are misshapen, hard and sticky, which can result in them getting stuck in blood vessels and clog them. This can cause severe pain crisis, infections, organ damage, low blood counts, stroke and other serious health problems.

Be The Match has also launched an informative online video called "You Are My Match" to raise awareness of the need for more Black or African American donors on the Be The Match Registry to help Black patients battling sickle cell disease find a potentially life-saving match. The video features a 4-year-old girl named Ruby from Lubbock, TX, who has been hospitalized more than 24 times and had three surgeries due to her sickle cell. Ruby's doctors are recommending a blood stem cell or marrow transplant due to the severity of her condition, but she does not have a perfect match on the Be The Match Registry.

Part of the challenge Black patients like Ruby face when searching for a perfect match is low representation of Black or African Americans on the Be The Match Registry. Of the 22 million potential donors on the Be The Match Registry, just 4 percent are Black or African American. Because ethnicity plays a role in finding a match, Black patients will only find a perfect match 23% of the time, which is much lower than other ethnicities, such as White patients, who will find a match 77% of the time.

To learn how to access free resources, read stories about people cured of sickle cell disease following a marrow or stem cell transplant and to join the Be The Match Registry, visit: http://www.sicklecellconnect.com.

Virtual Event Series:Episodes will be streamed via http://www.sicklecellconnect.comwebpage and viewable on Be The Match Social Channels.

Episode 1: What is sickle cell disease?September 10thfrom 12:00 12:30 p.m. CDT We'll chat about sickle cell disease basics with pediatric hematologist Staci Arnold, MD, hear sickle cell warrior Genesis' storyandlearn about barriers and disparities that sickle cell patients face from the Health Equity Manager at Be The Match.

Episode 2: Living with sickle cell diseaseSeptember 17th from 12:00 12:30 p.m. CDT We'll chat with a Be The Match Patient Navigator and Social Worker about the free resources available to sickle cell disease patients and hear from the founder of My Three Sicklers Foundation.

Episode 3:The future of sickle cell diseaseSeptember24th from 12:00 1:00p.m. CDT We'll cover transplant and gene therapy with Staci Arnold, MD and a certified genetic counselor from BeTheMatch. Hear about our policy efforts for sickle cell disease, meet sickle cell warriorDakhiyon, seehow Nia Imani Franklin, former Miss America, is advocating for more diverse donors on the Be The Match Registry, plus watch a live swabbing event!

Continue reading here:
Be The Match Presents "Sickle Cell Connect" Virtual Event Series To Raise Awareness Of Treatment Options And Marrow Transplants As A Cure...

Betty Lin-Fisher: Men, take care of your health – Akron Beacon Journal

Tom Fister has been a doting husband to his wife of 41 years, Sue.

Sue has been in and out of the hospital in the last year with complications after her second bout of acute myelogenous leukemia (AML). Last year, she had an umbilical cord stem cell transplant. That was 15 years after she first had the same leukemia.

Tom Fister, 69, was so focused on his wife and her care that the self-described "hard-headed man" ignored his own health to the point where he could have died, his doctor said.

The Copley man was on medication for high-blood pressure, but otherwise did not know he had other health complications.

He was slowly having a harder time walking from the parking deck at University Hospitals to go visit his wife daily before the COVID-19 virus shut down access to the hospitals and the shelter-in-place orders went into effect.

On March 13, Fister got up, showered and went in and checked himself into the emergency room.

"I spent a month in the hospital and three and a half weeks in the ICU," he said. "I pretty much just ran myself down."

When he went to the hospital, doctors discovered he was in acute heart failure and kidney failure and had pulmonary hypertension and severe aortic stenosis, which is a severe narrowing of the aortic valve, said Dr. Joseph Lahorra, a cardiothoracic surgeon and chairman of the Cleveland Clinic Akron General heart, vascular and thoracic department.

Severe aortic stenosis is a chronic and progressive disease that is fatal if untreated, Lahorra said.

"He basically was not following up with anybody because he was taking care of his wife," Lahorra said. Fister also was concerned if he got evaluated for his medical conditions, it would take away from his focus on his wifes care.

Fister is "a very altruistic guy," said Lahorra, and a prime example of men represented in a Cleveland Clinic study released earlier this week.

The national survey by Cleveland Clinic revealed that the COVID-19 pandemic is affecting both the mental and physical health of men. Some men are negatively impacted, while others are making healthier choices.

In an online survey among about 1,000 U.S. males 18 and older, Cleveland Clinic found that 77% of men report their stress level has increased as a result of COVID-19, 59% of men say they have felt isolated during the pandemic and nearly half (45%) of men say their emotional/mental health has worsened during the pandemic.

The survey was issued as part of Cleveland Clinics fifth annual educational campaign, "MENtion It," which aims to address the fact that men often do not talk about health issues or take steps to prevent them.

This year, the Clinic wanted to see what sort of effect the pandemic has had on men over the past six months and what their outlook is.

Here are a few other findings:

Three-in-five men (59%) feel COVID-19 has had a greater negative impact on their mental health than the 2008 recession.

66% of men say they rarely talk about the impact COVID-19 has had on their mental health.

Half of men (48%) have put off seeing a doctor for non-COVID-19 related health issues. That is even higher among men ages 18 to 34 (56%).

While some are struggling, COVID-19 has also inspired healthier habits in some. Nearly half of men (45%) feel healthier now and 22% are exercising more.

While 64% dont see an end to the COVID-19 outbreak in sight, the majority (71%) still remain optimistic about the future as the world continues to battle COVID-19, suggesting the pandemic hasnt dampened spirits completely.

"We couldnt take the temperature on the state of mens health this year without focusing on the one thing that has affected every person in this country and beyond," said Dr. Eric Klein, chairman of Cleveland Clinics Glickman Urological and Kidney Institute. "Many men are finding themselves in new and different roles as a result of this pandemic; for example, they are out of work or are working around the clock at home looking after kids with their partners all while worrying about their familys health and their own health. Its no surprise that mental health rose to the top as a critical issue in this years survey.

"We want to remind men that their health shouldnt take a back seat, especially during a pandemic," Klein said. "If youre experiencing symptoms that indicate a real health issue, dont be afraid to come to the hospital or schedule an appointment with a health care provider, either virtually or in person. Your health is too important not to."

For Fister, once he got to the hospital, doctors had to stabilize his health, including getting him on dialysis three times a week.

Doctors wanted to do whats called a TAVR procedure, a relatively new procedure that has been a paradigm shift for patients and doctors, Lahorra said. The procedure eliminates the need for open-heart surgery in some patients, which would obviously require a much-longer recovery time. In a TAVR procedure, the aortic valve is opened up through the groin and patients can go home the next day.

But for Fister, even proceeding with the TAVR was considered risky, given his initial medical issues. So doctors temporarily opened the valve with a balloon to give him a few months to stabilize his other health issues. He had the TAVR procedure in July, performed by Lahorra and cardiologist Dr. Anmar Kanaan.

Doctors also wanted to keep Fister out of the hospital during the height of the COVID-19 pandemic last spring because he was a severe risk.

"He is the exact patient who if he got COVID, he would not do well. He would do very poorly. We discussed that with him," Lahorra said.

Hospitals have seen patients who were avoiding getting care for fear of contracting COVID-19, to the detriment of their health, he said.

But now, however, data have shown hospitals are safe, even for people at high riks for COVID-19 complications, he said.

"This is a vital message to get out. Continue with your routine health care and certainly for more urgent acute problems, definitely get seen. The environment is very safe," Lahorra said.

Fister is grateful for what he calls his "medical miracle." He feels great now and just got trained to do peritoneal dialysis at home. His wife, Sue, was just moved to a rehab facility and he hopes she will be able to come home soon.

Fister said hes a fairly private person, but agreed to talk about his medical journey because "there are people who might be helped from this," he said. "If I can help some people, thats why were talking today."

Beacon Journal consumer columnist and medical reporter Betty Lin-Fisher can be reached at 330-996-3724 or blinfisher@thebeaconjournal.com. Follow her @blinfisherABJ on Twitter or http://www.facebook.com/BettyLinFisherABJ and see all her stories at http://www.beaconjournal.com/topics/linfisher

Continued here:
Betty Lin-Fisher: Men, take care of your health - Akron Beacon Journal